Plasma-only ctDNA-Guided MRD Detection in Patients with CRC-Response

被引：3
|
作者：
Parikh, Aparna R. [1 ,2 ]
Corcoran, Ryan B. [1 ,2 ]
机构：
[1] Massachusetts Gen Hosp, Ctr Canc, Div Hematol & Oncol, Dept Med, Boston, MA 02114 USA
[2] Harvard Med Sch, Boston, MA 02115 USA
来源：
CLINICAL CANCER RESEARCH | 2021年 / 27卷 / 23期
关键词：
D O I：
10.1158/1078-0432.CCR-21-3306
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：6614 / 6615
页数：2
相关论文
共 50 条
  • [21] Detection of ctDNA in the plasma of patients with papillary thyroid carcinoma
    Li, Huiqiang
    Zhao, Jiangman
    Zhang, Jianhua
    Wang, Congren
    Li, Mingzhu
    Wu, Shouxin
    Su, Zijian
    Pan, Qunxiong
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2019, 18 (05) : 3389 - 3396
  • [22] A tumor-informed, hybrid-capture based ctDNA assay for minimal residual disease (MRD) detection in colorectal cancer (CRC) patients after curative surgery
    Han, S-W.
    Heo, S.
    Lim, Y.
    Lee, W.
    Kim, H-P.
    Kim, S. Y.
    Bang, D.
    Park, K. J.
    Oh, S. T.
    Yoo, C. S.
    Kang, S-B.
    Kim, Y-J.
    Kim, T-Y.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S710 - S711
  • [23] Detection of minimal residual disease and prediction of recurrence in breast cancer using a plasma-only circulating tumor DNA assay
    Janni, W.
    Rack, B.
    Friedl, T. W. P.
    Hartkopf, A. D.
    Wiesmueller, L.
    Pfister, K.
    Mergel, F.
    Fink, A.
    Braun, T.
    Mehmeti, F.
    Uhl, N.
    De Gregorio, A.
    Huober, J.
    Fehm, T.
    Mueller, V.
    Rich, T. A.
    Dustin, D. J.
    Zhang, S.
    Huesmann, S. T.
    ESMO OPEN, 2025, 10 (04)
  • [24] Minimal residual disease (MRD) detection using a tumour naive circulating tumour DNA (ctDNA) assay in patients (pts) with resected colorectal cancer (CRC) in the phase III ASCOLT trial
    Day, D.
    Starus, A.
    Gebski, V.
    Simes, J.
    Hayes, T.
    Padinharakam, S.
    Strickland, A. H.
    Briscoe, K.
    Varma, S.
    Barnet, M.
    Jackson, C.
    Horvath, L. G.
    Price, T. J.
    Tebbutt, N.
    Karki, B.
    Diakos, C. I.
    Chia, J.
    Toh, H. C.
    Jones, F. S.
    Segelov, E.
    ANNALS OF ONCOLOGY, 2023, 34 : S426 - S427
  • [25] Patient-specific tumor-informed circulating tumor DNA (ctDNA) analysis for molecular residual disease (MRD) detection in surgical patients with stage I-IV colorectal cancer (CRC).
    Cao, Di
    Wang, Fu-Long
    Li, Cong
    Zhang, Rong-Xin
    Wu, Xiao-Jun
    Li, Liren
    Lu, Zhen-Hai
    Pan, Zhi-Zhong
    Lin, Jun-zhong
    Wu, Miaoqing
    Liu, Yifan
    Lv, Guangzhao
    Li, Min
    Wang, Chenyang
    Li, Xi
    Chen, Gong
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 213 - 213
  • [26] Ultrasensitive plasma ctDNA KRAS assay for detection, prognosis, and assessment of therapeutic response in patients with unresectable pancreatic ductal adenocarcinoma
    Chen, Inna
    Raymond, Victoria M.
    Geis, Jennifer A.
    Collisson, Eric A.
    Jensen, Benny V.
    Hermann, Kirstine L.
    Erlander, Mark G.
    Tempero, Margaret
    Johansen, Julia S.
    ONCOTARGET, 2017, 8 (58) : 97769 - 97786
  • [27] A real-world study of longitudinal urinary ctDNA monitoring of minimal residual disease (MRD) in patients with muscle invasive urothelial carcinoma followed in parallel with plasma based ctDNA
    Tan, A.
    ANNALS OF ONCOLOGY, 2023, 34 : S1220 - S1220
  • [28] Analytical Validation of the Ultra-Sensitive Tumor-Informed Haystack MRD Assay for Detection of ctDNA in Solid Tumor Patients
    Prathapam, R.
    Champion, K.
    Blakely, K.
    Powers, S.
    Graham, J.
    Tigh, A.
    Goos-Root, D.
    Sass, C.
    Angeloni, T.
    Acab, A.
    Gutierrez, R.
    Harding, J.
    Liu, Y.
    Cleveland, C.
    Clark, M.
    Downton, M.
    Helfrich-Kroger, A.
    Querfurth, R.
    Brown, E.
    Maramica, I.
    Glodosky, C.
    Haskell, B.
    Kaplan, J.
    Ryder, M.
    Bramlett, K.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2024, 26 (11): : S100 - S100
  • [29] PLASMA BASED CELL-FREE CIRCULATING TUMOR DNA (CTDNA) ASSESSMENT FOR NON-INVASIVE DETECTION OF COLORECTAL CANCER (CRC)
    Dean, Jason
    He, Yupeng
    Raymond, Victoria
    Kim, Seung Tae
    Lee, Jeeyun
    Kim, Hee Cheol
    Jaimovich, Ariel
    Talasaz, AmirAli
    GASTROENTEROLOGY, 2020, 158 (06) : S369 - S369
  • [30] Plasma-onlymultiomic minimal residual disease (MRD) testing in 2,000 consecutive patients with colorectal cancer (CRC).
    Pedersen, Katrina Sophia
    Tan, Benjamin R.
    Zuo, Xiaotong
    Kiedrowski, Lesli A.
    Bucheit, Leslie
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 28 - 28
12345